Literature DB >> 27710960

Molecular Understanding of Non-Transfusion-Dependent Thalassemia Associated with Hemoglobin E-β-Thalassemia in Northeast Thailand.

Supawadee Yamsri1, Naruwat Pakdee, Goonnapa Fucharoen, Kanokwan Sanchaisuriya, Supan Fucharoen.   

Abstract

Non-transfusion-dependent thalassemia (NTDT) is associated with various forms of thalassemia and genetic modifiers. We report the molecular basis of NTDT in hemoglobin (Hb) E-β-thalassemia disease. This study was done in 73 adult patients encountered at the prenatal diagnosis center of Khon Kaen University, Northeast Thailand. Hematological parameters and Hb patterns were collected, and α- and β-globin gene mutations were determined. Multiple single-nucleotide polymorphisms (SNPs) including the rs7482144/Gγ-XmnI polymorphism, rs2297339, rs2838513, rs4895441, and rs9399137 in the HBS1L-MYB gene, rs4671393 and rs11886868 in the BCL11A gene, and G176AfsX179 in the KLF1 gene were examined. Five β0-thalassemia mutations and a severe β+-thalassemia mutation in trans to the βE gene were identified. No significant difference in hematological parameters was observed among β-thalassemia genotypes. Coinheritance of α-thalassemia was observed in 31 of the 73 subjects (42.5%). Four SNPs including Gγ-XmnI, rs2297339, rs4895441, and rs9399137 of HBS1L-MYB were found to be associated with high Hb F levels in 39 (53.4%) subjects. The molecular basis of NTDT in the remaining 3 (4.1%) cases could not be defined. These results indicate multiple genetic factors in NTDT patients and underline the importance of complete genotyping to provide proper management, make clinical predictions, and improve genetic counseling.
© 2016 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27710960     DOI: 10.1159/000449120

Source DB:  PubMed          Journal:  Acta Haematol        ISSN: 0001-5792            Impact factor:   2.195


  4 in total

1.  Protective BCL11A and HBS1L-MYB polymorphisms in a cohort of 102 Congolese patients suffering from sickle cell anemia.

Authors:  Tite Minga Mikobi; Prosper Tshilobo Lukusa; Michel Ntetani Aloni; Aimé Zola Lumaka; Didine Kinkodi Kaba; Koenraad Devriendt; Gert Matthijs; Jean Marie Mbuyi Muamba; Valérie Race
Journal:  J Clin Lab Anal       Date:  2017-03-23       Impact factor: 2.352

2.  Genetic predictions of life expectancy in southern Thai patients with β0-thalassemia/Hb E.

Authors:  Manit Nuinoon; Patchara Rattanaporn; Thongchai Benjchareonwong; Anuchit Choowet; Komsai Suwanno; Ngamta Saekoo; Krongjit Lekpetch; Orapan Thipthara; Saovaros Svasti; Suthat Fucharoen
Journal:  Biomed Rep       Date:  2022-05-06

3.  α0-thalassemia in affected fetuses with hemoglobin E-β0-thalassemia disease in a high-risk population in Thailand.

Authors:  Supawadee Yamsri; Simaporn Prommetta; Hataichanok Srivorakun; Wachiraporn Taweenan; Kanokwan Sanchaisuriya; Attawut Chaibunruang; Goonnapa Fucharoen; Supan Fucharoen
Journal:  Am J Transl Res       Date:  2022-02-15       Impact factor: 4.060

4.  Molecular Analysis of Non-Transfusion Dependent Thalassemia Associated with Hemoglobin E-β-Thalassemia Disease without α-Thalassemia.

Authors:  Paramee Phanrahan; Supawadee Yamsri; Nattiya Teawtrakul; Goonnapa Fucharoen; Kanokwan Sanchaisuriya; Supan Fucharoen
Journal:  Mediterr J Hematol Infect Dis       Date:  2019-07-01       Impact factor: 2.576

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.